학술논문
Lopinavir/ritonavir (LPV/r) combined with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC) in antiretroviral-naïve subjects: 96-week safety and efficacy results of the PROGRESS study: P185
Document Type
Academic Journal
Author
Source
HIV Medicine. Apr 01, 2012 13 Suppl 1:69-69
Subject
Language
English
ISSN
1464-2662